Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.
暂无分享,去创建一个
H. Johnsen | E. Holmberg | J. Lamvik | S. Lenhoff | I. Turesson | J. Westin | P. Gimsing | L. Brinch | I. Dahl | E. Löfvenberg | J. L. Nielsen | K. Carlson | I. Nesthus | F. Wisløff | E. Hippe | J. Westin | F. Wislöff | M. Hjorth | S. Rödjer | M. Carlsson | Margaretha S Carlsson | E. Löfvenberg